Lantern Pharma
Lantern Pharma is a personalized cancer therapy founded in 2013.
2
Funding Rounds
$7.4m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Ma*** Ma********* | - | - | |
| Vi*** Ch***** | - | - | |
| Da*** Si********* | - | - | - |
| Fr****** G. Pr********* | - | - | - |
| Pa*** Sh**** | - | - |
Funding series
Funding Series Analysis
The company Lantern Pharma has raised a total of $3.7m in funding over 2 rounds.
Key Insights:
- Latern Pharma Series A round, May 2017: $3.7m
- Lantern Pharma funding round, May 2017: $3.7m
Latern Pharma Series A round, May 2017
$3.7m
Lantern Pharma funding round, May 2017
$3.7m
Industries
Lantern Pharma is active in the following industries:
- Oncology
- Biology
- Biotechnology
- Internal medicine
- Healthcare
- Medicine
- Technology
- Cancer
- Consumer biotechnology
- Engineering
- Pharmaceutical industry
- Biopharmaceutical
- Biomedical engineering
- Drug discovery
- Genomics
- Bioinformatics
- Artificial Intelligence (AI)